LAU-7b

April 8, 2016April 8, 2016

Laurent Pharmaceuticals’ Drug Candidate for Cystic Fibrosis Supported by Anges Québec, Other Investors

Cystic Fibrosis, News

A series of Canadian so-called angel investors, primarily Anges Québec, are partnering with Aligo Innovation and other private investors to help Cystic Fibrosis Canada support the growth of Laurent Pharmaceuticals, a Montreal-based private biopharma ... Read more

March 23, 2016May 13, 2016

Laurent Pharma to Prepare Phase 2 Trial for Cystic Fibrosis on Heels of New Financing Round

Cystic Fibrosis, News

Montreal-based Laurent Pharmaceuticals recently announced the closing of a financing round, led by new investor Cystic Fibrosis Canada. The round included existing investors such as Aligo Innovation LP and Anges Quebec, and ... Read more

June 23, 2015November 5, 2015

Laurent Pharmaceuticals Reveals Promising Results for LAU-7b Therapeutic in Cystic Fibrosis Patients

Cystic Fibrosis, News

Laurent Pharmaceuticals Inc., a biopharmaceutical company with a clinical development program for cystic fibrosis (CF), recently announced promising data on its Phase 1b clinical trial with LAU-7b in adult CF ... Read more